Hybrid immunity’s role in curbing COVID-19: Canadian study sheds light on vaccine-infection synergy

Study evaluates the impact of hybrid immunity on SARS-CoV-2 antibody levels in Canadian adults, revealing that hybrid immunity, combining vaccination and recovery from infection, significantly reduces COVID-19 morbidity and mortality.

Evotec SE reports first half-year 2024 results on 14 August 2024 – Biotech Investments

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec SE reports first half-year 2024 results on 14 August 2024 07.08.2024 / 13:00 CET/CEST The issuer is

August 8, 2024

Data, Design, and Discovery: Andrew Buchanan’s Impact on Biologics Innovation

Andrew Buchanan on the Future of Biologics and AI

November 10, 2023

Scurvy may be making a comeback amid economic strain

The scourge of scurvy, which is caused by vitamin C deficiency, may be re-emerging amid the cost of living crisis and the rise in weight

October 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.